Page last updated: 2024-08-24

atorvastatin and Carcinoma, Squamous Cell

atorvastatin has been researched along with Carcinoma, Squamous Cell in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, X; Dong, CD; Ge, Y; Li, X; Li, Z; Liu, K; Lu, Q; Peng, F; Wu, X; Yuan, Q; Zhao, J1
Adalsteinsson, JA; Feng, H; Hu, C; Jonasson, JG; Kristjansson, AK; Muzumdar, S; Olafsdottir, GH; Ratner, D; Silverberg, JI; Tryggvadottir, L; Ungar, J; Waldman, R; Wu, R1
Biselli, JM; Biselli-Chicote, PM; Goloni-Bertollo, EM; Lotierzo, AT; Paravino, ÉC1
Islam, M; Kumar, B; Sharma, S; Teknos, TN1

Other Studies

4 other study(ies) available for atorvastatin and Carcinoma, Squamous Cell

ArticleYear
Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma.
    Aging, 2019, 11-07, Volume: 11, Issue:21

    Topics: Atorvastatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Esophageal Neoplasms; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phosphorylation; Proteome; Xenograft Model Antitumor Assays

2019
Statins are associated with increased risk of squamous cell carcinoma of the skin: a whole-population study from Iceland.
    Archives of dermatological research, 2022, Volume: 314, Issue:8

    Topics: Atorvastatin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Case-Control Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iceland; Simvastatin; Skin Neoplasms

2022
Atorvastatin increases oxidative stress and inhibits cell migration of oral squamous cell carcinoma in vitro.
    Oral oncology, 2019, Volume: 90

    Topics: Atorvastatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Mouth Neoplasms; Neovascularization, Physiologic; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Vascular Endothelial Growth Factor A

2019
Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.
    Oral oncology, 2013, Volume: 49, Issue:8

    Topics: Animals; Atorvastatin; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Signaling System; Mice; Neoplasm Metastasis; Phosphorylation; Pyrroles; rho GTP-Binding Proteins; rhoC GTP-Binding Protein; STAT3 Transcription Factor

2013